GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2426 - 2450** of **4050** in total

« First

‹ Prev

…

94

95

96

97

98

99

100

101

102

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgA	Patient 1	6	moderate	G62222PE	338
IgA	Patient 2	24	mild	G49916XD	338
IgM	Patient 2	3	mild	G25407RZ	338
IgM	Patient 2	3	mild	G51872EK	338
IgA	Patient 1	10	moderate	G21675ZL	339
IgA	Patient 1	6	moderate	G76615YG	339
IgA	Patient 1	6	moderate	G86541PE	339
IgM	Patient 2	15	mild	G93351GM	339
IgM	Patient 4	12	mild	G76615YG	339
IgA	Patient 1	10	moderate	G58547FH	340
IgA	Patient 1	22	moderate	G69912LP	340
IgA	Patient 1	6	moderate	G91537AT	340
IgA	Patient 2	24	mild	G68461PT	340
IgM	Patient 2	15	mild	G30839DN	340
IgM	Patient 2	24	mild	G30839DN	340
IgA	Patient 2	3	mild	G37036SF	340
IgA	Patient 2	3	mild	G48898TH	340
IgA	Patient 2	3	mild	G64669AQ	340
IgA	Patient 2	3	mild	G82348BZ	340
IgM	Patient 4	12	mild	G00048MO	340
IgA	Patient 1	22	moderate	G78074HX	341
IgA	Patient 1	6	moderate	G73271MD	341
IgA	Patient 2	15	mild	G67045LB	341
IgA	Patient 2	24	mild	G57449OF	341
IgM	Patient 2	15	mild	G09609EN	341